OpenVSafe by OpenVAERS
Search V-safe

NHP-24214-98546

3 vaccinations 5 coded responses 36 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
800 / CO
Registered
2022-07-07
Relationship
Child or adolescent in my care
Guardian
KVD-48952-12807
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-06
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-07
    Registered in v-safe
  3. 2022-07-07
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-09
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-12
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-13
    Health check-in — day 7, dose 1, under 3
    Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite, Vomiting · Be unable to do your normal daily activities
    Under 3 check-in
  9. 2022-07-20
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-07-27
    Health check-in — day 21, dose 1, under 3
    Feeling: Fair
    Under 3 check-in
  11. 2022-08-04
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-10
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-08-17
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-08-19
    Dose 2 — Pfizer-BioNTech
    Co-administered: Hib:Tetanus
  15. 2022-08-19
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-08-20
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-08-21
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-22
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-08-23
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-08-24
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-08-25
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  22. 2022-08-26
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  23. 2022-09-02
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-09-09
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2022-09-16
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2022-09-23
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  27. 2022-09-30
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  28. 2022-10-27
    Dose 3 — Pfizer-BioNTech
  29. 2022-10-27
    Health check-in — day 0, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  30. 2022-10-28
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  31. 2022-10-29
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  32. 2022-10-30
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  33. 2022-11-02
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  34. 2022-11-03
    Health check-in — day 7, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  35. 2022-11-17
    Survey response — day 21, dose 3, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Good
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-11-24
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  37. 2022-12-01
    Survey response — day 35, dose 3, under 3
    MedDRA: Decreased appetite, Fatigue, Pyrexia, Vomiting — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Vomiting, fever, fatigue, loss of appetite
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-12-08
    Survey response — day 42, dose 3, under 3
    MedDRA: Hand-foot-and-mouth disease — Feeling: Good
    Free text: Hand foot and mouth disease
    MedDRA releases: 2024-11 · check-in free text available
  39. 2023-01-26
    Survey response — 3 months, dose 3, under 3
    MedDRA: Ear infection, Eye infection, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  40. 2023-01-26
    Report sent to call center — 3 months, dose 3, under 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  41. 2023-01-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  42. 2023-04-27
    Survey response — 6 months, dose 3, under 3
    MedDRA: Ear infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  43. 2023-04-27
    Report sent to call center — 6 months, dose 3, under 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2023-04-28

Vaccinations

DoseDateManufacturerCo-administered
12022-07-06Pfizer-BioNTech No
22022-08-19Pfizer-BioNTech Hib:Tetanus
32022-10-27Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 21, dose 3, under 3

2022-11-17

Symptoms: RSV

Release 12 (Under 3) — day 35, dose 3, under 3

2022-12-01

Symptoms: Vomiting, fever, fatigue, loss of appetite

Release 12 (Under 3) — day 42, dose 3, under 3

2022-12-08

Symptoms: Hand foot and mouth disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDecreased appetite · · ✓
SDEar infection · · ✓
SDEye infection · · ✓
SDFatigue · · ✓
SDHand-foot-and-mouth disease · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRespiratory syncytial virus infection · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…